Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
더 큰 신호는 AI가 데모를 넘어 예산, 규칙, 보안 절차, 자본 배분 속으로 들어가고 있다는 점이다.
출처: BusinessWire; BioSpace; Precision Medicine Online; CocoLoop, CocoLoop.